HCPLive Network
HCPLive TV
Patricia Finn, MD, president of the American Thoracic Society, highlights 3 presentations at the 2014 American Thoracic Society International Conference that link science and health equality.
Although diagnosing pneumonia is the same regardless of whether the patient is immunocompetent or immunocompromised, the physician needs to understand the patient’s host defense.
Although researchers discovered a plasma biomarker that can predict the development of acute respiratory distress syndrome in emergency room patients, the condition is usually already present.
The theme Patricia Finn, MD, president of the American Thoracic Society, embraced at this year’s international conference was health equality.
Inflammatory bowel disease patients are already benefiting from technology advancements in healthcare, but there are barriers to providing care through telemedicine, Raymond Cross, MD.
Since pancreatic cancer is so rare, screening among the general population is not worthwhile, according to Randall Brand, MD. Instead, physicians should only screen those individuals considered "high risk."
Inflammatory bowel disease patients can benefit greatly from telemedicine, because physicians can interact more frequently with patients, according to Raymond Cross, MD.
The side effects present in treatments for the hepatitis C virus are a barrier not only to increasing treatment completion, but also the initiation of the treatment.
Treatment rates among hepatitis C virus patients remained low partly because side effects are high, according to Mindie H. Nguyen, MD, assistant professor of medicine at the Stanford University Medical Center.
$AD300x250BB$